Cameron Turtle's Net Worth
$10.5 Million
Who is Cameron Turtle?
Cameron Turtle has an estimated net worth of $10.5 Million. This is based on reported shares across multiple companies, which include Spyre Therapeutics, Inc., BridgeBio Pharma, Inc., Eidos Therapeutics, Inc., and Oruka Therapeutics, Inc..
SEC CIK
Cameron Turtle's CIK is 0001758363
Past Insider Trading and Trends
2020 was Cameron Turtle's most active year for acquiring shares with 33 total transactions. Cameron Turtle's most active month to acquire stocks was the month of August. 2020 was Cameron Turtle's most active year for disposing of shares, totalling 67 transactions. Cameron Turtle's most active month to dispose stocks was the month of October. 2020 saw Cameron Turtle paying a total of $1,579,126.24 for 264,805 shares, this is the most they've acquired in one year. In 2020 Cameron Turtle cashed out on 311,305 shares for a total of $10,168,953.23, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Spyre Therapeutics, Inc. (AGLE) No price found
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.05% | 400 |
$9.82 | $3,928.00 | 746.91K |
Feb 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
| +3,136.26% | 723.44K |
—
|
—
| 746.51K |
Nov 22 - Nov 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BridgeBio Pharma, Inc. (BBIO) Snapshot price: $30.7
See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$38.14 | -$1,226,684.04 | 12.57K |
Scheduled
|
Dec 28
| ||
Form 4
|
—
|
0
|
$32.02 | -$150,180.84 | 12.57K |
Scheduled
|
Nov 24 - Nov 25
| ||
Form 4
|
—
|
0
|
$29.53 | -$62,624.75 | 12.57K |
Scheduled
|
Nov 5
| ||
Form 4
|
—
|
0
|
$20.42 | -$500,957.74 | 12.57K |
Scheduled
|
Sep 30
| ||
Form 4
|
—
|
0
|
$29.51 | -$62,524.25 | 12.57K |
Scheduled
|
Sep 18
| ||
Form 4
|
—
|
0
|
$27.03 | -$50,151.75 | 12.57K |
Scheduled
|
Sep 15
| ||
Form 4
|
—
|
0
|
$17.68 | -$69,367.00 | 12.57K |
Scheduled
|
Sep 11
| ||
Form 4
| +27.94% | 2.75K |
—
|
—
| 12.57K |
Sep 1
| |||
Form 4
|
—
|
0
|
$16.44 | -$324,303.04 | 9.82K |
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
—
|
0
|
$24.51 | -$30,027.60 | 9.82K |
Scheduled
|
Apr 27
| ||
Form 4
|
—
|
0
|
$22.02 | -$80,357.60 | 9.82K |
Scheduled
|
Apr 8
| ||
Form 4
|
—
|
0
|
$27.14 | -$40,564.20 | 9.82K |
Scheduled
|
Feb 11
| ||
Form 4
| -22.22% | -2.81K |
$25.69 | -$270,210.99 | 9.82K |
Scheduled
|
Jan 8
| ||
Form 4
|
∞
| 12.63K |
—
|
—
| 12.63K |
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Eidos Therapeutics, Inc. No price found
Chief Business Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -50.70K |
—
|
—
|
0
|
Jan 26
| |||
Form 4
|
—
|
0
|
$62.81 | -$2,574,801.07 | 50.62K |
Dec 15
| |||
Form 4
| -22.75% | -14.91K |
$74.51 | -$999,227.30 | 50.62K |
Nov 11
| |||
Form 4
| -7.09% | -5.00K |
$42.60 | -$775,453.57 | 65.53K |
Scheduled
|
Nov 2
| ||
Form 4
|
—
|
0
|
$32.00 | -$75,000.00 | 70.53K |
Scheduled
|
Sep 10
| ||
Form 4
| -6.62% | -5.00K |
$26.57 | -$333,449.88 | 70.53K |
Scheduled
|
Aug 3
| ||
Form 4
| +0.50% | 376 |
$41.57 | $15,631.64 | 75.53K |
May 31
| |||
Form 4
|
—
|
0
|
$32.00 | -$75,000.00 | 75.16K |
Scheduled
|
May 26
| ||
Form 4
| -6.24% | -5.00K |
$27.02 | -$342,433.21 | 75.16K |
Scheduled
|
May 1
| ||
Form 4
| -5.87% | -5.00K |
$34.06 | -$562,139.79 | 80.16K |
Scheduled
|
Feb 3
| ||
Form 4
|
—
|
0
|
$36.23 | -$460,451.63 | 85.16K |
Dec 6
| |||
Form 4
| -10.51% | -10.00K |
$55.75 | -$557,501.77 | 85.16K |
Nov 20
| |||
Form 4
| -4.99% | -5.00K |
$41.58 | -$207,922.94 | 95.16K |
Sep 4
| |||
Form 4
| -6.66% | -7.15K |
$21.83 | -$282,173.50 | 100.16K |
Nov 30 - Jun 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Oruka Therapeutics, Inc. (ABIO) Snapshot price: $2.48
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||